Completed Studies

  1. A phase III, multicenter, randomized, double-blinded, comparative study to evaluate the efficacy and safety of ceftaroline fosamil versus vancomycin plus aztreonam in the treatment of patients with complicated bacterial skin and soft tissue infections with evidence of systemic inflammatory response or underlying comorbidities 
  2. Distribution of PCV 13 serotype Streptococcus pneumoniae in adults 50 years and older presenting to select hospitals and clinics with radiographically-confirmed community-acquired pneumonia (CAP) 
  3. Safety and immunogenicity of a spli-viron AS03A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults 
  4. A randomized, parallel, comparative study to evaluate the safety and efficacy of liposomal amphotericin B and amphotericin B deoxycholate with or without flucytosine followed by fluconazole, for the treatment of cryptococcal meningitis
  5. A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine 
  6. A clinical study to assess the immunogenicity and safety of a monovalent 2009 influenza A (H1N1) vaccine in an area with low-level epidemics of pandemic influenza 
  7. The Madin-Darby canine kidney cell culture derived influenza A/H5N1 vaccine: A Phase I trial in Taiwan 
  8. Prospective observation study on treatment outcome of patients with vancomycin-resistant enterococcus bloodstream infection: the role of linezolid 
  9. Prospective observation study on treatment outcome of patients with carbapenem-resistant Acinetobacter baumannii bloodstream infection: the role of tigecycline 
  10. Prospective observation study on treatment outcome of patients with candidemia: the role of echinocandins
  11. A Randomized, Double-blind, Controlled Phase I Trial to Evaluate the Safety, Tolerability, and Immunogenicity of DCB07010 Adjuvant Given Intranasally at Ascending Dose Levels and Co-administered with Trivalent Inactivated Influenza Virus Antigen 
  12. An Open-Label, Dose-Escalating Phase 1 Safety Study of HibmLT Vaccine in Healthy Volunteers